Logo Goletty

Uric Acid Inhibition Activity of Annona muricata L Leave Extract in Hyperuricemia induced Wistar Rat
Journal Title Advances in Pure and Applied Chemistry
Journal Abbreviation APAC
Publisher Group World Science Publisher
Website http://worldsciencepublisher.org/journals/
PDF (258 kb)
   
Title Uric Acid Inhibition Activity of Annona muricata L Leave Extract in Hyperuricemia induced Wistar Rat
Authors Manuaba, Putra
Abstract This research aims to find a cure of gout, base on the utilization of Annona muricata. The research was started with descriptive study to explore active components of Annona muricata leaf and followed by an experimental study to investigate uric acid inhibition activity of the leaf extract in hyperuricemia induced wistar rat. We observed three dominant components, i.e. 2,3-dihidrobenzofuran; 3-ethoxy-1,4,4a,5,6,7,8,8a-octahydroisoquinoline;  2-cyclohexen-1-one, 4-hydroxy-3,5,6-trimethyl-4-(3-oxo-1-butenyl) which were probably active to inhibit uric acid formation in hyperuricemic induced wistar rat. In this study, n-buthnol was applied for partitioning the relatively pure compound. The n-buthanol extract obtained was then applied to cure hyperuricemic rat induced by a mixture of chicken livers and Gnetum gnemon a high purine diet. It was obtained, that the highest extract dose of  400 mg/kgBW was able to inhibit the formation of uric acid in hyperuricemic rat. It can be concluded that Annona muricata leaf extracted with n-buthanol in a dose of 400 mg/kg BW has an ability to inhibit further formation uric acid in hyperuricemic rat. Therefore, this natural plant is potent to develop for hyperuricemic medicine.    
Publisher World Science Publisher
Date 2012-11-14
Source 2167-0854
Rights Copyright NoticeProposed Creative Commons Copyright Notices1. Proposed Policy for Journals That Offer Open AccessAuthors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work´s authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal´s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).Proposed Policy for Journals That Offer Delayed Open AccessAuthors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication, with the work [SPECIFY PERIOD OF TIME] after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work´s authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal´s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

 

See other article in the same Issue


Goletty © 2024